Given miR-708-5p’s ability to enhance p53 and CHOP protein expression, we examined the molecular and phenotypic consequences of combinatory miR-708-5p and chemotherapy treatments in lung cancer cells. The gene discussed is TP53; the disease is lung carcinoma.